1. European Medicines Agency . Carmustine Obvius: summary of product characteristics, 2018. Available: https://www.ema.europa.eu/en/documents/product-information/carmustine-obvius-epar-product-information_de.pdf [Accessed 20 Sep 2020].
2. Tillomed Pharma GmbH . Carmubris® Pulver und Lösungsmittel Zur Herstellung einer Infusionslösung, 2018. Available: http://www.tillomed-pharma.de/fachinformationen/Fachinfo_Carmubris.pdf [Accessed 20 Sep 2020].
3. Degradation of carmustine in aqueous media;Laskar;J Pharm Sci,1977
4. Stability of carmustine--kinetics and compatibility during administration;Fredriksson;Acta Pharm Suec,1986
5. Effects of temperature, solution composition, and type of container on the stability and absorption of carmustine;Hadji-Minaglou-Gonzalvez;Clin Ther,1992